Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-071459
Filing Date
2024-08-21
Accepted
2024-08-21 16:15:02
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4008
  Complete submission text file 0001213900-24-071459.txt   5434
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Issuer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address
Linsley Wayne (Reporting) CIK: 0001809972 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38803 | Film No.: 241228885